Research published in Molecular Therapy develops a gene therapy approach for glaucoma in the lab

Fight for Sight logo

25 March 2020
Source: Fight for Sight

Glaucoma is the second leading cause of blindness for which there is currently no cure. In a lab setting, the researcher used a gene-editing technique called CRISPR to alter genetic information when transferred into eye cells using a harmless virus. By switching off a gene called aquaporin 1, researchers found that the gene therapy prevented the build-up of fluid –

Read more Research published in Molecular Therapy develops a gene therapy approach for glaucoma in the lab